Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN269297 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Calreticulin (CALR) antibody
- Antibody type
- Polyclonal
- Description
- Unpurified
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Vial size
- 0.1 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Endoplasmic reticulum pathology and stress response in neurons precede programmed necrosis after neonatal hypoxia-ischemia.
Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus.
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
Chavez-Valdez R, Flock DL, Martin LJ, Northington FJ
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2016 Feb;48:58-70
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2016 Feb;48:58-70
Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus.
Varjak M, Saul S, Arike L, Lulla A, Peil L, Merits A
Journal of virology 2013 Sep;87(18):10295-312
Journal of virology 2013 Sep;87(18):10295-312
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Leslie EM, Watkins PB, Kim RB, Brouwer KL
The Journal of pharmacology and experimental therapeutics 2007 Jun;321(3):1170-8
The Journal of pharmacology and experimental therapeutics 2007 Jun;321(3):1170-8
Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, Corvazier E, Combrie R, Fressinaud E, Meyer D, Nurden AT, Enouf J
Blood 2006 Oct 15;108(8):2587-95
Blood 2006 Oct 15;108(8):2587-95
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC